Jason Springs

Founder of Endpoint Health

Jason Springs

Backed by

Sources

Grifols signs global collaboration and licensing agreement with Endpoint Health to develop and commercialize Antithrombin III for Sepsis — 2022-06

Browse all founders · Browse investors